A Study to Evaluate the Reactogenicity, Safety, and Immunogenicity of the Third Generation Hepatitis B Vaccine
Clinical trial NCT02692170 · COMPLETED
Trial details
- NCT number
- NCT02692170
- Sponsor
- Aribio Lab Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-07
- Primary completion
- 2015-05-28
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.